ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,073,721 | -6.0% | 2,076,575 | +2.2% | 0.00% | – |
| Q2 2023 | $3,270,800 | -41.1% | 2,031,553 | +6.1% | 0.00% | -100.0% |
| Q1 2023 | $5,552,276 | +91718.7% | 1,914,578 | +3.8% | 0.00% | 0.0% |
| Q4 2022 | $6,047 | -99.9% | 1,843,618 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $6,695,000 | -49.8% | 1,771,324 | +3.5% | 0.00% | -50.0% |
| Q2 2022 | $13,332,000 | -14.6% | 1,711,450 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $15,617,000 | -38.8% | 1,681,106 | +3.7% | 0.00% | -33.3% |
| Q4 2021 | $25,538,000 | -3.1% | 1,620,465 | +10.0% | 0.00% | -25.0% |
| Q3 2021 | $26,363,000 | +12.0% | 1,472,822 | -2.7% | 0.00% | +33.3% |
| Q2 2021 | $23,547,000 | +15.5% | 1,514,324 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $20,383,000 | -13.8% | 1,419,436 | +17.8% | 0.00% | -25.0% |
| Q4 2020 | $23,645,000 | +71.6% | 1,204,541 | +13.3% | 0.00% | +33.3% |
| Q3 2020 | $13,782,000 | +6.9% | 1,063,435 | +20.2% | 0.00% | 0.0% |
| Q2 2020 | $12,889,000 | +83.0% | 884,674 | +6.9% | 0.00% | +50.0% |
| Q1 2020 | $7,043,000 | -70.8% | 827,730 | -43.6% | 0.00% | -33.3% |
| Q4 2019 | $24,158,000 | +145.7% | 1,466,894 | +110.6% | 0.00% | +50.0% |
| Q3 2019 | $9,833,000 | -18.1% | 696,492 | +16.7% | 0.00% | -33.3% |
| Q2 2019 | $12,005,000 | -44.7% | 596,983 | +9.4% | 0.00% | -50.0% |
| Q1 2019 | $21,699,000 | -37.3% | 545,911 | -45.2% | 0.01% | +20.0% |
| Q4 2018 | $34,606,000 | +85.4% | 996,156 | +120.6% | 0.01% | 0.0% |
| Q3 2018 | $18,670,000 | +19.4% | 451,532 | +6.1% | 0.01% | 0.0% |
| Q2 2018 | $15,643,000 | +14.0% | 425,680 | +21.0% | 0.01% | +25.0% |
| Q1 2018 | $13,718,000 | +285.1% | 351,753 | +78.7% | 0.00% | +300.0% |
| Q4 2017 | $3,562,000 | +12.0% | 196,841 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $3,179,000 | +20.6% | 192,110 | +2.0% | 0.00% | 0.0% |
| Q2 2017 | $2,637,000 | -26.1% | 188,425 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $3,568,000 | +51.1% | 173,639 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $2,362,000 | -24.6% | 166,408 | +13.6% | 0.00% | -50.0% |
| Q3 2016 | $3,132,000 | +1.0% | 146,463 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $3,100,000 | +27.4% | 137,725 | +7.7% | 0.00% | +100.0% |
| Q1 2016 | $2,433,000 | -30.3% | 127,880 | -3.3% | 0.00% | -50.0% |
| Q4 2015 | $3,492,000 | -8.1% | 132,254 | +9.4% | 0.00% | 0.0% |
| Q3 2015 | $3,800,000 | +11.8% | 120,893 | +87.6% | 0.00% | 0.0% |
| Q2 2015 | $3,399,000 | +43.5% | 64,431 | +13.0% | 0.00% | +100.0% |
| Q1 2015 | $2,369,000 | +151.8% | 57,002 | +62.0% | 0.00% | 0.0% |
| Q4 2014 | $941,000 | – | 35,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |